DRS Dilip Road (DRSDILIP)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 23.68% indicates efficient capital deployment.
• Piotroski F-Score of 7/9 suggests generally healthy financials.
• Promoter holding of 74.95% aligns management interests with minority shareholders.
• Latest quarter sales of ₹97 Cr and net profit of ₹5 Cr show a functioning, revenue-generating operation.

Concerns

• Sales growth of 2.47% and profit growth of 5.31% are weak relative to a P/E of 26.
• PEG of 6.68 suggests the stock is expensive for its growth rate.
• No dividend means no income cushion; returns depend entirely on price appreciation.
• Book value, ROE, and debt/equity are unavailable, limiting a Graham-style margin-of-safety analysis.

AI Analysis

Looking at DRS Dilip Road, I first remind myself that a business must be understood before a price ever matters. This is a small logistics player with a market cap of ₹163 Cr, and while I see a decent ROCE of 23.68%, I do not see a wide moat. A promoter holding of 74.95% is good, as it aligns owners with management, but high promoter holding alone does not create a competitive advantage. The latest quarter shows sales of ₹97 Cr and net profit of ₹5 Cr, a margin around 5%, which is not terrible but does not suggest meaningful pricing power. Sales growth of only 2.47% and profit growth of 5.31% are pedestrian. For a business growing this slowly, a P/E of 26 times is far from a bargain. The PEG of 6.68 screams overpayment unless growth accelerates dramatically. The absence of book value and ROE data bothers me; Graham insisted on knowing what tangible assets stand behind the equity. I cannot calculate a proper margin of safety without that. Positive points: Piotroski score of 7/9 suggests the company's financial health is reasonable, and return on capital employed is strong. Zero dividend means all returns must come from price appreciation or reinvestment, and at this growth rate, reinvestment does not appear to be working wonders. The stock has already more than doubled from its 52-week low of ₹52.25 to ₹113.55, so much may be priced in. In the spirit of Graham, I would wait for a lower price, better balance sheet visibility, and evidence of accelerating growth before considering this a disciplined investment.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer